Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450353 · ClinicalTrials.gov registry record
Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
A clinical trial of Allogeneic Transplantation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT06450353: Recruiting study of Allogeneic Transplantation, sponsored by M.D. Anderson Cancer Center.
NCT06450353 is a study of Allogeneic Transplantation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06450353, a study of Allogeneic Transplantation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).
Conditions Studied
Interventions
- BEHAVIORAL Patient Ancestry Questionnaires
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2024-05-31 |
| Est. Completion | 2029-06-01 |
What NCT06450353 shows while recruiting
NCT06450353 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Allogeneic Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Patient Ancestry Questionnaires is the first listed.
NCT06450353 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06450353 about?
NCT06450353 is a clinical study titled "Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation". To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).
What is the current status of trial NCT06450353?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2024-05-31. Estimated completion is 2029-06-01.
What conditions does trial NCT06450353 study?
This clinical trial studies the following conditions: Allogeneic Transplantation.
What interventions are being tested in trial NCT06450353?
The interventions under investigation include: Patient Ancestry Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT06450353?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06450353 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allogeneic Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI